was basically as described by Dano Chemicals, except that the serum dilution was adjusted so that the vitamin B12 activity was measured using both 0 1 and 0 25 ml of serum (corresponding to dilutions of 1:100 and 1 :40 respectively). The tests were done in duplicate. All the assays were carried out by one of us (C.D.) who has been using the method for five years. It was first established that there was insufficient diurnal or daily variation to invalidate Received for publication 7 February 1969. the study and that the normal levels were between 120 and 600 ,ug/ml.
Where serum B12 is estimated using Lactobacillus leichmanii, the phenomenon of inhibition is encountered not infrequently. Boczarow (1961) reported on the effect of penicillin on the test organism and found that penicillin therapy invalidated the test. However, Watts (1967) claimed that the dilution and heating involved in the assay procedure resulted in inactivation of the antibiotic, except where novobiocin was given. In view of this discrepancy we decided to measure the incidence of the phenomenon of inhibition and its possible relationship to antibiotic and drug therapy.
MATERIAL AND METHOD Serum vitamin B12 was estimated using Lactobacillus leichmanii (ATCC 7830) and DANO-B12 assay medium (Dano Chemicals, Copenhagen) . The method (Thompson, Dietrich, and Elvehjem, 1950; Spray, 1955) was basically as described by Dano Chemicals, except that the serum dilution was adjusted so that the vitamin B12 activity was measured using both 0 1 and 0 25 ml of serum (corresponding to dilutions of 1:100 and 1 :40 respectively).
The tests were done in duplicate. All the assays were carried out by one of us (C.D.) who has been using the method for five years. It was first established that there was insufficient diurnal or daily variation to invalidate Received for publication 7 February 1969. the study and that the normal levels were between 120 and 600 ,ug/ml.
The Euglena gracilis and 57Co methods were performed according to the descriptions of Ross (1952) and Lau, Gottlieb, Wasserman, and Herbert (1965) .
The incidence of inhibition was determined by assessing the results of the last 750 consecutive vitamin B12 assays, 480 from cases in a psychiatric hospital and 270 from general medical cases. All the accepted cases showed a marked reduction (usually more than twofold) of the vitamin B12 level with the larger volume of serum (1:40 dilution). Drug ingestion was then investigated.
When it was realized that ampicillin was implicated, tests in vivo and in vitro were carried out with this antibiotic. Eleven patients who required therapy were studied.
Blood was taken to establish a basal serum vitamin B12 level before ampicillin was given in a dose of 250 mg intramuscularly every eight hours. Subsequent samples were collected half an hour after the morning injection on the third and fifth treatment days. A final sample was collected between five and seven days after the cessation of therapy. A similar procedure was adopted in 10 patients receiving chlorpromazine hydrochloride 50 mg twice daily.
A further five patients were studied during ampicillin therapy in order that parallel vitamin B12 levels by the radioisotope and/or E. gracilis methods could be determined in the inhibitory phase.
Tests in vitro with ampicillin and other antibiotics were carried out by adding the antibiotics to the serum before the assay. The quantities added were adjusted to give levels which might be encountered in vivo. from 50 to 10,4,4g/ml, or in case 31, in which both pre-and post-antibiotic levels were above 600 4uzg/ml, from 440 to 350,uug/ml on the fifth day.
A further five patients were studied to check the effect of ampicillin therapy on vitamin B,2 levels, as measured by the radioisotope and E. gracilis methods. Because of insufficient serum it was not possible to perform all three methods on all samples. The first samples were collected before ampicillin therapy was begun, and the second on the third day of treatment (Table 11) . Three of the five (M.T., H.H., and M.E.H.) showed typical inhibition with L. leichmanii, but when measurements were performed by the other two methods levels of vitamin B,2 were within the normal range. The ampicillin levels in two of the sera that showed inhibition (M.T. and H.H.) were 0-4,sg and 3-1,4g per ml respec- ppjg/ml. Ampicillin was added to give levels of 1-0 to 10-OOg per ml and it was shown that 4 0,4g and above produced inhibition. The specificity of the inhibition was confirmed, as shown in Table IV , where 2 and 8, g of ampicillin were added to the pre-antibiotic serum of case 26 (Table II) . Slight inhibition was seen in the 0 25 ml sample at 2,pg, and complete inhibition in 0-1 ml and 0 25 ml at 8 g. This patient subsequently showed inhibition on the fifth day of ampicillin therapy.
Ampicillin sensivity ofL. leichmanii The organism was tested using the standard assay medium in the presence of ampicillin. The organism was found to be highly sensitive, giving a minimum inhibitory concentration of 0 04,g per ml. Effect of drugs on vitamin B12 levels using the Lactobacillus leichmanii method Table VI because no significant differences at the expected therapeutic blood levels 2 to 6 jsg were seen. per ml. Sera from patients, free from inhibition One patient who received ampicillin followed by before ampicillin therapy, showed a degree of inchlorpromazine therapy showed complete inhibition hibition similar to that seen in vitro on the addition on ampicillin but no inhibition while receiving of comparable concentrations of ampicillin. It is of chlorpromazine (Fig. 1 Ross (1952) showed that several antibiotics, including penicillin, had no effect on E. gracilis when added in vitro in concentrations comparable to those found during treatment. We have confirmed that this also applies in vivo. The radioisotope method is also unaffected. Herbert, Gottlieb, and Altschule (1965) reported chlorpromazine inhibition of E. gracilis in vitamin B12 assays. In the correspondence that followed, Forshaw and Harwood (1966) showed that this did not occur when L. leichmanii was used as the test organism. Davis and Nicol (1966) thought that there might be differences in the effect of Largactil and Thorazine, the latter being the trade name under which chlorpromazine is sold in the United States. However, they failed to show inhibition with either, although it is not clear which test organism was used. Our results confirm those of Forshaw and Harwood with the L. leichmanii assay and suggest that this is a valuable routine method in a psychiatric hospital (of 2,000 beds) where chlorpromazine and other psychotropic drugs are used extensively.
We are grateful to Dr J. L. Withey and Dr J. H. Jones for carrying out the Euglena and radioisotopic assays.
